Skip to search formSkip to main contentSkip to account menu

Cancer Therapy Evaluation Program

Known as: CTEP 
The program within the Division of Cancer Treatment and Diagnosis (DCTD) of the NCI which plans, assesses, and coordinates all aspects of clinical… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Abstract OT2-1-06: E2112: A randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
Background: Epigenetic alterations in the genome, including abnormal DNA methylation and histone hypoacetylation, initiate and… 
2015
2015
An analysis of corrective action plans to address slow accruing NCI-held IND early phase trials.
6577 Background: In 2011, NCI began requesting Corrective Action Plans (CAP) for early phase trials accruing < 50% of their… 
2013
2013
Adult participation in oncology clinical trials by indication, race, and age.
e17586 Background: According to the National Cancer Institute (NCI), approximately 3 percent of adult cancer patients participate… 
Review
2011
Review
2011
Evaluation of cancer trial eligibility criteria (with focus on non-AIDS-defining cancers) for inclusion of persons with HIV infection.
6092 Background: Non-AIDS-defining cancers (NADC) have become a significant cause of mortality in persons with HIV-infection. In… 
2011
2011
Analysis of minority-based community clinical oncology program (MBCCOP) accrual activity.
6070 Background: Minority-Based CCOPs were established in 1990 to improve access to NCI-sponsored clinical trials for minority… 
2010
2010
Early indicators of accrual success: Time-to-first-patient and accrual performance at an anticipated enrollment milestone-A study of NCI-CTEP-sponsored clinical trials.
6001 Background: This research investigates whether indicators of time from trial opening to first enrollment and accrual… 
2009
2009
A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of CTEP-sponsored studies.
CRA6509 Background: Post-activation barriers to oncology clinical trial accruals are well documented; however, potential barriers… 
2009
2009
A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of CTEP-sponsored studies.
CRA6509 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings… 
2007
2007
Rapid Communication SOLICITATION FOR LETTERS OF INTENT Clinical trials Preclinical experiments E7389, Halichondrin B analog (NSC 707389)
  • 2007
  • Corpus ID: 46410751
CTEP is soliciting for phase 1 combination and phase 2 single-agent clinical trials of E7389, a halichondrin B analogue tubulin… 
Review
1990
Review
1990
Need for uniformity in collection and reporting of data in cancer clinical trials.
The National Cancer Institute (NCI) has recently publicized the need for increasing accrual of patients to clinical trials. A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)